Today's Rundown | Welcome to Fierce’s daily coronavirus roundup. In order to bring you the most comprehensive and up-to-date information relating to the pandemic, we are publishing additional stories and all of the day’s coronavirus-related news in a PM edition. If you would prefer not to receive this newsletter, you may opt out at any time by clicking here. | |
|
Trump to invoke Defense Production Act to boost medical supplies Fast-moving Regeneron eyes summer clinical trial for COVID-19 antibody cocktail therapy J&J sets sights on November for COVID-19 vaccine trial Hospitals to Congress: Don't forget us in COVID-19 stimulus package Pfizer, BioNTech strike COVID-19 deal, commit multiple R&D sites to vaccine development Biopharma roundup: Lilly steps up to expand Indiana testing; Trump sought to expand investigational drug studies Healthcare roundup: Match Day goes on, but without pomp; New advice for pregnant women FDA urges clinical researchers to go virtual in response to COVID-19 pandemic Are IL-6 inhibitors one key to COVID-19? EUSA Pharma joins Sanofi, Regeneron in rolling out trials More than 100 Australian doctors, healthcare professionals stuck on ship due to COVID-19 restrictions CMS will recommend hospitals, doctors limit 'non-essential, elective' procedures Bayer preps U.S. donation of malaria med chloroquine to help in COVID-19 fight: report Qiagen aims to more than quadruple its COVID-19 reagent production in 6 weeks Cannes Lions Health postpones June advertising festival, looks to reschedule in Oct. Featured Story | | | Wednesday, March 18, 2020 President Donald Trump said Wednesday that he would invoke the Defense Production Act to mitigate challenges with obtaining medical supplies. |
|
|---|
|
Top Stories Wednesday, March 18, 2020 During the 2018 outbreak of Ebola, Regeneron quickly developed a promising monoclonal antibody triplet therapy that’s now under review by the FDA. Now, amid the ongoing coronavirus pandemic, the biotech is at it again, planning to advance a antibody cocktail into the clinic by early summer. Wednesday, March 18, 2020 Johnson & Johnson expects to land on a COVID-19 vaccine candidate by the end of the month, en route to clinical trials in early November, Paul Stoffels, the company’s chief scientific officer, told CNBC on Tuesday. Along the way, J&J will set up processes for widespread production of the vaccine. Wednesday, March 18, 2020 Strained by the loss of revenue from elective procedures and the looming crisis caused by coronavirus, hospitals are asking Congress for some financial relief. Tuesday, March 17, 2020 Pfizer has teamed up with BioNTech to co-develop and distribute a mRNA vaccine against COVID-19 outside of China. The partners plan to use multiple R&D sites in the U.S. and Germany to accelerate the progress of a vaccine that is due to begin clinical testing in humans by the end of April. Wednesday, March 18, 2020 Amid the frenzied push for drugs and vaccines, President Donald Trump sought to allow more testing of investigational medicines in patients with infections, the Wall Street Journal reports. FDA experts worried the move might put more patients at risk. Meanwhile, billionaire Bill Ackman urged the president to shut down the country for 30 days. Wednesday, March 18, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Wednesday, March 18, 2020 How can clinical trial sponsors help keep their research going amid the spreading coronavirus outbreak? Use virtual visits, phone interviews, self-administration and remote monitoring, the FDA says. That's according to a new final guidance (PDF) document the agency published Wednesday describing the potentially unavoidable deviations from trial protocols that may have to be made to maintain the safety of study participants and providers. Wednesday, March 18, 2020 Sanofi and Regeneron are putting their hopes in IL-6 inhibitor Kevzara as a possible therapy for COVID-19 with clinical trials underway. Now, a second IL-6 med rolling into trial in an Italian hospital, potentially showing promise for the class as a whole. Tuesday, March 17, 2020 They went on what was supposed to be an unconventional medical convention, but now more than 100 Australian doctors, dentists, and medical experts are trapped on a cruise ship off the coast of Chile. Wednesday, March 18, 2020 The Centers for Medicare & Medicaid Services (CMS) will release recommendations today that call for doctors and hospitals to limit “non-essential, elective” medical and surgical procedures, including dental procedures. Wednesday, March 18, 2020 Biopharma companies have scrambled to start new R&D projects and repurpose existing medicines amid the COVID-19 crisis. Now, Bayer is getting ready to donate an older treatment to the U.S. government for potential use, Axios reports. Wednesday, March 18, 2020 Qiagen is looking to steeply ramp up its worldwide production of the RNA test reagents used to perform certain COVID-19 diagnostics. By the end of the year, the company hopes to provide for more than 20 million monthly tests. Wednesday, March 18, 2020 Cannes Lions Health officially moved its annual June conference and awards to October. The decision to postpone the entire Cannes Lions advertising festival comes amid many global event postponements and cancellations due to the COVID-19 pandemic. |
